Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
Biotech
A look at the R&D landscape in obesity, led by GLP-1s
If you’re feeling like the obesity pipeline filled up overnight, you’re not alone. A new analysis from IQVIA takes a look at the drugs in development.
Annalee Armstrong
,
Gabrielle Masson
Mar 19, 2024 8:00am
Parexel CEO to step down
Mar 18, 2024 4:40pm
Biden directs agencies to boost R&D for women's health
Mar 18, 2024 11:07am
TFS HealthScience hops into new region with Australia base
Mar 14, 2024 7:05am
Fortrea to become 'pure-play' CRO after sale of businesses
Mar 12, 2024 3:35pm
Lilly's lebrikizumab clears eczema in people with skin of color
Mar 11, 2024 9:24am